Exelixis, Inc. (EXEL)

Nasdaq · Healthcare · Biotechnology
$64.63-1.82%As of 2026-11-22 · USD
Last session low $64.45Last session high $66.94
52-week low $39.7152-week high $73.69
Market cap
$15.77B
Sector
Healthcare
P/E (TTM)
19.4x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)45.7In the neutral range (30 to 70)
MACD (12, 26, 9)1.06Below its signal line (1.93); histogram -0.87
Bollinger %B (20, 2)7%Inside the bands (63.98 to 73.30)
SMA 2068.64Price is 5.8% below
SMA 5063.22Price is 2.2% above
SMA 20052.86Price is 22.3% above
ATR (20)3.26% of priceAverage true range per day
52-week position73%In the upper part of the 39.71 to 73.69 range

About Exelixis, Inc.

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Latest fiscal yearEnded 2025-12-31: revenue of $2.32B and an operating margin of 38.5%.

More in Biotechnology